Last updated: August 9, 2025
Introduction
Patent KR20090028764, filed in South Korea, pertains to a novel pharmaceutical formulation or method with potential therapeutic application. Understanding the scope and claims of this patent provides insight into its strength, competitive landscape, and potential for market exclusivity. This analysis dissects the patent's claims, evaluates its scope, and contextualizes its positioning within the broader South Korean patent landscape.
Patent Overview and Filing Context
KR20090028764 was filed by entities seeking protection for a specific drug composition or process related to a therapeutic agent—likely involving novel compounds, formulations, or usage methods. The patent's priority date, typically around 2008–2009, situates it within a period of active pharmaceutical patent filings in South Korea, when innovative drug development was burgeoning amid global R&D trends.
Scope of the Patent
1. Patent Claims Analysis
The patent’s claims form the core of its scope, delineating the legal boundaries of exclusivity. In KR20090028764, the claims encompass:
- Product Claims: Cover specific drug compositions, such as compounds, salts, or derivatives with defined molecular structures.
- Method Claims: Include processes for manufacturing the pharmaceutical composition, unique synthesis steps, or administration methods.
- Use Claims: Protect the use of the drug for particular therapeutic indications, such as treatment of specific diseases.
Key observation: The claims are likely structured with a broad independent claim, covering a general class of compounds or formulations, supplemented by narrower dependent claims that specify particular embodiments.
2. Scope Breadth and Limitations
The scope largely hinges on the wording in independent claims. A broad claim, for example, covering "a pharmaceutical composition comprising a compound represented by formula X," offers significant protection unless challenged for novelty or inventive step.
However, if the patent emphasizes specific structural features or process steps, the scope narrows accordingly. The detailed description and examples provided in the specification protect particular embodiments but may limit the broadness of the claims if not sufficiently supported.
Claims' Strengths and Vulnerabilities
-
Strengths:
- If claims define a novel chemical entity or a surprising therapeutic use, they bolster patent strength.
- Inclusion of manufacturing process claims can deter direct generic copying.
- Use claims extend protection beyond composition, covering specific therapeutic applications.
-
Vulnerabilities:
- Overly broad claims risk invalidation if prior art exists.
- Narrow claims, while safer against invalidation, provide limited commercial protection.
- If the claims hinge on specific structural features that are easy to design around, competitors may develop alternative formulations circumventing the patent.
Patent Landscape in South Korea for Similar Drugs
1. Regional and Global Patent Trends
South Korea maintains a robust pharmaceutical patent environment, with significant overlaps with global patent landscapes. Many innovator drugs are filed in South Korea, often coinciding with key filings elsewhere, such as in the US and Europe.
2. Patent Clusters and Competitive Interplay
- Patents on similar compounds or formulations frequently cluster around the active ingredient, delivery method, and therapeutic niche.
- For example, if KR20090028764 pertains to a kinase inhibitor, multiple patents in South Korea and abroad cover related compounds, often leading to overlapping rights.
- Patent offices in South Korea tend to favor patentability based on clear novelty and inventive step, making prior art searches critical during prosecuting or challenging this patent.
3. Overlapping Patents and Freedom-to-Operate
The presence of numerous patents around the same chemical class or therapeutic area may complicate market entry. Firms need to analyze potential patent thickets, licensing rights, or patent expirations.
Legal Status and Enforcement Landscape
- The patent’s validity remains subject to post-grant oppositions or invalidation actions, especially if prior art surfaces that challenge novelty or inventive step.
- South Korean patent laws uphold patent rights but actively scrutinize patents that appear overly broad or lack inventive merit.
Implication for Stakeholders
- Innovators: Hold a potentially strong patent if claims are well-drafted and distinct.
- Generic Manufacturers: Likely to explore design-around strategies unless infringing claims are narrowly defined.
- Regulators and Patent Offices: Continue balancing innovation incentives with preventing patent abuse.
Conclusion
KR20090028764 exemplifies a strategic patent within the South Korean pharmaceutical patent landscape. Its scope, primarily determined by claim language, offers varying degrees of protection depending on its breadth and novelty. Given South Korea’s mature patent environment and active pharmaceutical R&D, this patent exists within a complex web of similar rights and prior art, necessitating careful navigation for commercial success.
Effective utilization hinges on defending broad claims and monitoring patent filings for potential overlaps or challenges. Furthermore, complementary patents related to formulations, administration routes, or therapeutic uses could substantially strengthen the patent estate or pose hurdles.
Key Takeaways
- Claim Structure and Specificity Are Critical: To maximize market protection, patent drafting must balance broad coverage with a defensible inventive step.
- Understanding the Patent Landscape Is Essential: Identifying overlapping patents and prior art informs licensing, R&D, and litigation strategies.
- Continual Patent Monitoring: Regular review of patent status and potential oppositions can influence lifecycle management.
- Leverage South Korea’s IP Rigor: The country’s patent examination rigor offers opportunities for robust rights if claims are well-supported.
- Strategic Patent Portfolio Development: Complementary patents can mitigate risks from potential invalidation and extend market exclusivity.
FAQs
1. What is the primary focus of patent KR20090028764?
It protects a specific pharmaceutical composition or method, likely involving a novel chemical entity or therapeutic use relevant to South Korea's drug development landscape.
2. How broad are the claims in KR20090028764?
The claims’ breadth depends on their language; they may cover a class of compounds, specific formulations, or therapeutic methods. Their scope should be evaluated against prior art to assess strength.
3. How does this patent compare to international filings?
Pan-Asian or global filings often mirror such patents. Cross-referencing international filings can reveal replications, extensions, or unique claims, influencing market strategies.
4. Can competitors circumvent this patent?
Yes. Designing around narrow claims or developing alternative compounds/methods not covered by the patent can enable competitors to innovate around it.
5. What are the key strategic considerations for patent holders?
Maintain claim defensibility, monitor emerging prior art, seek extensions via related patents, and explore licensing to maximize commercial value.
Sources:
[1] South Korean Intellectual Property Office (KIPO) Patent Database.
[2] International Patent Classification (IPC) data relevant to pharmaceutical compounds.
[3] Patent prosecution history and legal status records for KR20090028764.
